OutcomesAI, a healthcare technology company developing AI-powered tools to enhance nursing capacity, announced it has raised $10 million in seed funding led by Santé Ventures. The Boston-based company is developing a new model of scalable nursing that integrates artificial intelligence voice agents with licensed nurses, aiming to reduce costs, increase capacity, and provide patients with faster access to care. The funding will support commercial expansion into health systems, virtual care programs, and pharmaceutical partnerships.
The funding arrives amid a global nursing shortage projected to reach 13 million by 2030. Nurses today spend most of their time on triage, follow-ups, and care coordination, leaving only about one-third of each shift for direct patient care. As demand for specialty and virtual care surges—with wait times exceeding 30 days and a tenfold increase in patient messages—healthcare systems are struggling to maintain service quality without overextending their nursing staff.
OutcomesAI’s solution centers on its proprietary AI engine, Glia, which integrates intelligent voice agents with licensed nurses to manage patient interactions and clinical workflows. The AI agents handle inbound and outbound calls, symptom collection, scheduling, follow-ups, and patient education in multiple languages. Meanwhile, nurses are supported by productivity tools that include real-time scribing, automated documentation, and protocol guidance. This hybrid model increases nursing capacity by three to five times, reduces costs by up to 50 percent compared to outsourced triage services, and consistently enhances patient satisfaction scores.
The company’s approach emphasizes augmentation rather than replacement of clinical roles. By automating repetitive administrative and communication tasks, OutcomesAI enables nurses to focus on complex, high-value care. Its technology is already being validated through the OutcomesAI Collaboratory, a consortium of five leading health systems and virtual care providers launched in 2024 to test Glia’s safety, accuracy, and clinical performance. Early results indicate significant improvements in operational efficiency, including reductions of hundreds of nurse hours per month and doubled patient-to-nurse ratios.
With the new funding, OutcomesAI plans to scale enterprise partnerships, launch dedicated nursing service lines, and publish additional case studies demonstrating measurable return on investment. The company’s leadership team includes seasoned executives from Mayo Clinic, Amwell, Philips, Best Buy Health, and Biofourmis, bringing deep expertise in healthcare delivery, AI technology, and commercialization. Founder and CEO Kuldeep Singh Rajput, who previously founded Biofourmis, leads the company’s mission to redefine nursing for the digital era.
As part of the funding, several new members are joining the company’s Board of Directors, including Joe Cunningham, M.D., Founding Managing Director at Santé Ventures; Linda Finkel, Senior Advisor at AVIA; Dennis McWilliams, Managing Director at Santé Ventures; and Kevin White, Ph.D., founder of Provaxus, alongside Rajput.
KEY QUOTES:
“Healthcare is running out of nursing capacity, and incremental fixes won’t solve it. With OutcomesAI, we’re not replacing nurses — we’re multiplying them. By combining AI voice agents with licensed nursing teams, we give back time to the people at the center of care, reduce burnout, and build a sustainable, scalable model for the future.”
Kuldeep Singh Rajput, Founder and CEO of OutcomesAI
“With a projected shortfall of 13 million nurses by 2030, the industry is desperate for scalable solutions. We invested in OutcomesAI because they are rethinking how nursing capacity can be scaled — not with incremental fixes, but with a model that blends AI with clinical services to deliver measurable impact. We believe this approach has the potential to redefine virtual care and set a new standard for safety, empathy, and efficiency in healthcare.”
Joe Cunningham, M.D., Founding Managing Director, Santé Ventures
